Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NEE vs MRNA✓SelectedUSD · MRNANEE vs MRNA performance historyLatest closeAs of-0.41%11/20
Stock and ETF performance explorer

NEE vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+121.6%
MRNA return
+786.4%
Excess return
-664.8%
Maximum drawdown
-45.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.4%-2.2%+1.8%-0.4%
7D-2.0%-12.7%+10.7%-1.7%
30D+6.6%-20.7%+27.3%+7.0%
3M-1.1%+46.3%-47.4%-2.3%
6M-4.1%+305.2%-309.3%-10.0%
YTD+6.2%+561.2%-555.0%-3.1%
1Y+1.8%+772.1%-770.3%-8.4%
3Y+59.1%+147.0%-87.9%+49.1%
5Y+8.1%-26.1%+34.2%+4.8%
All+121.6%+786.4%-664.8%+92.6%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling